40-character summary: Four men in Germany face trial for selling €58M of Captagon linked to jihadist groups.

400-character summary: In Aachen, Germany, four men face trial for allegedly selling €58M ($63M) worth of Captagon tablets, a powerful amphetamine-based stimulant. Primarily produced in Syria and Lebanon, Captagon is linked to jihadist groups like ISIS, and its use has spread from the Middle East to Europe. The trial highlights the international drug trade and the need for international collaboration to combat this issue.

August 14, 2024
3 Articles